# South America Genomics Market > South America Genomics Market Research Report: By Application (Drug Discovery, Clinical Diagnostics, Personalized Medicine, Genetic Testing), By Technology (Sequencing, Microarray, PCR, CRISPR), By End Use (Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies) andBy Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 13.25% - **2024:** $ 5.83 Billion - **2025:** $ 6.6 Billion - **2035:** $ 22.92 Billion - **Key Players:** Illumina (US), Thermo Fisher Scientific (US), Roche (CH), Agilent Technologies (US), BGI Genomics (CN), Qiagen (DE), PerkinElmer (US), Eurofins Scientific (LU) **Report ID:** MRFR/MED/50708-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-america-genomics-market-52466 --- ## Market Summary ## **South America Genomics Market Overview** As per MRFR analysis, the South America Genomics Market Size was estimated at 3.02 (USD Billion) in 2023. The South America Genomics Market Industry is expected to grow from 3.25(USD Billion) in 2024 to 7.2 (USD Billion) by 2035. The South America Genomics Market CAGR (growth rate) is expected to be around 7.499% during the forecast period (2025 - 2035). ### **Key South America Genomics Market Trends Highlighted** The South America genomics market is undergoing substantial transformations as a result of a variety of factors, such as a heightened emphasis on personalized healthcare and precision medicine. In order to enhance health outcomes and disease management, governments in the region are investing in genomics research and infrastructure. Brazil and Argentina are promoting innovation by supporting local firms and research institutions, which are collaborating with academia and industry to advance genomic studies. The increasing prevalence of genetic disorders and chronic diseases is another significant market driver, which is motivating healthcare systems to implement genetic testing and sequencing technologies to improve diagnostic accuracy. Opportunities in the South American genomics market are expanding, particularly in the field of agricultural genomics. The potential for genomics to enhance crop yields and resistance to pests and diseases is increasing in countries like Brazil and Argentina, where agriculture is a critical industry. Furthermore, the development of bioinformatics is offering substantial assistance in data analysis, which has the potential to improve research in a variety of disciplines, such as ecology and medicine. Growth is also anticipated to be stimulated by the increasing accessibility of next-generation sequencing (NGS) technologies, which will enable a greater number of institutions to engage in genomics research. There is a growing emphasis on public-private partnerships to improve genomic capabilities, as evidenced by recent trends. These partnerships can enable the exchange of knowledge and the allocation of resources, thereby establishing South America as a competitive force in the global genomics industry. In addition, there is a growing interest among young scientists in pursuing careers in genomics, which is expected to propel the development of innovative projects and initiatives that are specifically designed to address the distinctive genetic diversity of the region. In general, the South American genomics market is undergoing a rapid transformation, which is being driven by both health concerns and agricultural opportunities. This is paving the way for future advancements. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ## **South America Genomics Market Drivers** ### **Rising Healthcare Expenditure** The increasing investment in healthcare systems across South America is crucial for the growth of the South America Genomics Market Industry. Governments in nations such as Brazil and Argentina have significantly elevated their healthcare budgets, with Brazil's Ministry of Health committing to a 10% annual increase in public healthcare funding. This hike facilitates enhanced Research and Development capabilities and the adoption of advanced genomic technologies.The Pan American Health Organization reports a steady rise in healthcare spending, which has increased from about 9% of GDP in the early 2010s to an estimated 14% by 2024. This trend thereby reinforces the infrastructure needed to support genomic research, making it a pivotal driver for the market's expansion. ### **Increasing Prevalence of Genetic Disorders** The notable rise in genetic disorders throughout South America is a significant driver for the South America Genomics Market Industry. For instance, observed data highlights that congenital disorders affect approximately 1 in every 33 newborns in Latin America, according to the World Health Organization. To counter this health crisis, local organizations like the Brazilian Society of Genetics are pushing for research funding and genomic initiatives.This rising prevalence generates a demand for advanced genomic testing and therapies, motivating governments and healthcare providers to invest in genomics-based solutions. ### **Advancements in Genomic Technologies** The rapid technological innovations in sequencing and analysis tools are transforming the South America Genomics Market Industry. Technologies such as next-generation sequencing (NGS) are becoming increasingly accessible. A report from the Brazilian National Bioethics Committee showcases that the costs associated with genomic sequencing have decreased dramatically, allowing for more widespread access. The reduction of sequencing costs by over 70% over the last decade has paved the way for extensive genomic applications, from personalized medicine to novel therapeutic development, further fueling market growth. ### **Collaborations and Partnerships in Genomic Research** The trend of collaborations between universities, research institutions, and biotechnology companies is a driving force behind the growth of the South America Genomics Market Industry. Collaborations such as the joint venture formed by the University of São Paulo and local biotech companies have facilitated significant advancements in genomic research, yielding new insights into local genetic profiles. These initiatives are crucial for developing targeted therapies and enhancing the understanding of genetic diseases prevalent in South America. Such partnerships are not only fostering innovation but also bridging technological gaps, driving the overall growth in the genomics sector. ## **South America Genomics Market Segment Insights** ### **Genomics Market Application Insights** The South America Genomics Market, particularly in the Application segment, showcases significant growth potential driven by various critical applications, including Drug Discovery, Clinical Diagnostics, Personalized Medicine, and Genetic Testing. Drug Discovery plays a pivotal role, particularly given the rising need for targeted therapies that address complex diseases prevalent within the region. In Clinical Diagnostics, advancements are yielding more accurate and timely results, which enhance patient care and streamline healthcare processes.  Personalized Medicine is gaining traction as it tailors treatments to individual patient profiles, optimizing efficacy and minimizing adverse effects.Genetic Testing continues to hold importance, particularly in identifying genetic disorders and potential health risks, making it a cornerstone in preventative healthcare strategies. Overall, the rising interest in genomics research, supportive government policies, and increasing awareness among healthcare professionals drive the applications within the South America Genomics Market, fostering innovation and enhancing service delivery in the healthcare sector.  As research and development activities expand throughout the region, these applications present numerous opportunities for growth and advancement, catering to the evolving needs of the population.Furthermore, with a diverse demographic profile, South America exhibits unique challenges and advantages in implementing genomic technologies, thereby contributing to a dynamic market landscape. Emphasizing the importance of these applications highlights their relevance in combating health challenges and improving healthcare outcomes, making the South America Genomics Market an increasingly attractive space for both existing and emerging industry players. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ### **Genomics Market Technology Insights** The Technology segment of the South America Genomics Market showcases a rapidly evolving landscape with its various applications, notably Sequencing, Microarray, PCR, and CRISPR. With Sequencing technology leading the charge, it allows for extensive genetic analysis and personal genomics, significantly enhancing Research and Development activities in both clinical and agricultural sectors. Microarray technology serves as a pivotal tool in genomics, enabling the simultaneous analysis of multiple genes, which is crucial for disease diagnosis and biomarker discovery. PCR (Polymerase Chain Reaction) technology plays a vital role in amplifying DNA sequences, thus fostering advancements in diagnostics and therapeutic innovations. CRISPR technology, a groundbreaking tool for gene editing, is making strides in genetic research and therapeutic applications by allowing precise modifications to DNA, which could impact various diseases prevalent in the region. The overall growth of this segment is driven by an increased focus on personalized medicine and the need for efficient and accurate genomic solutions in South America, enriching the South America Genomics Market data and statistics.Each of these technologies is essential for addressing the growing demand for advanced healthcare solutions, facilitating innovations that are tailored to local health challenges, and contributing significantly to the market dynamics. ### **Genomics Market End Use Insights** The South America Genomics Market exhibits a diverse range of end-use applications that are crucial for health care advancements and scientific progress. Hospitals are significant users of genomics technologies, providing personalized medicine and comprehensive genetic testing services, which enhance patient care and treatment efficacy. Diagnostic Laboratories play a crucial role in genetic testing, driving demand for innovative genomics solutions to improve disease diagnosis and management. Research Institutes leverage genomics data for groundbreaking studies, contributing to the collective understanding of genetic disorders and potential therapeutic pathways. Pharmaceutical Companies utilize genomics in drug discovery and development processes, leading to more targeted therapies that cater to specific genetic profiles and enhancing their R&D capability. As the South America Genomics Market continues to evolve, these end-use segments drive substantial growth, supported by technological advancements and an increasing focus on precision medicine. Collectively, they represent a significant force in transforming health care delivery and improving patient outcomes in the region. The continued investment and emphasis on genomics are pivotal to addressing prevalent health challenges in South America, making this market both dynamic and promising. ### **Genomics Market Regional Insights** The South America Genomics Market reflects a diverse landscape characterized by varying regional dynamics. Brazil, the largest market within the region, has a significant presence due to its advanced Research and Development capabilities and investment in biotechnology, making it a leader in genomics applications. Mexico also plays a vital role, driven by government initiatives promoting genomics research and healthcare improvements, displaying robust growth potential.  Argentina contributes notably with increasing emphasis on agricultural genomics and personalized medicine, which enhances the capacity to address local health challenges.The Rest of South America encompasses a range of emerging markets recognizing the importance of genomics in healthcare innovation, agricultural efficiency, and bioinformatics development. This regional segmentation illustrates the varying degrees of investments and regulatory support in genomics, impacting the overall South America Genomics Market statistics and driving market growth. The region is leveraging advancements in genomics to address public health challenges, optimize agricultural outputs, and enhance the biotechnology sector, fueled by a growing awareness of genomics' potential to reshape industries and improve quality of life. ## **South America Genomics Market Key Players and Competitive Insights** The South America Genomics Market is experiencing significant growth, driven by advancements in technologies, increasing government funding, and rising consumer awareness about personalized medicine. The competitive landscape shows a mix of established players and emerging companies focusing on various aspects of genomics, including research and development, diagnostics, and therapeutic applications.  Factors such as the rising prevalence of genetic disorders, growing investments in genomic research, and a rising demand for advanced sequencing technologies are further propelling market expansion. Each company is attempting to carve out significant market shares in this evolving sector while also navigating regulatory environments that can differ from one country to another within the region.Agilent Technologies has established a strong foothold in the South America Genomics Market through its innovative offerings in genomics research and diagnostics. The company is well-recognized for its cutting-edge solutions in next-generation sequencing, microarrays, and targeted sequencing, essential in both academic and clinical settings.  With a comprehensive product portfolio and strong customer service, Agilent Technologies has built a reputation for reliability and quality in South America. Its ability to collaborate with local research institutions and healthcare providers has enhanced its market presence, helping develop tailored solutions that meet regional needs. The company also benefits from a robust supply chain that ensures accessibility and affordability of its advanced genomic technologies across various South American countries.Roche is another key player in the South America Genomics Market, known for its extensive range of diagnostic and research products that cater to the genetic testing domain.  The company focuses on integrating its diagnostics with therapeutic products, positioning itself at the forefront of personalized medicine in the region. Roche offers a diverse portfolio, including genomic assays and tools for molecular biology, which are vital for advanced genomic studies and clinical diagnostics. Its strategic partnerships and mergers, and acquisitions have further strengthened its market presence by enhancing its technological capabilities and expanding its reach into various South American markets.  Roche’s commitment to research and development ensures a continuous pipeline of innovative solutions aimed at addressing genetic disorders prevalent in the region, thereby solidifying its role as a prominent player in the genomics landscape of South America. ### **Key Companies in the South America Genomics Market Include:** ## **South America Genomics Market Industry Developments** The South America Genomics Market has experienced notable developments recently, particularly with advancements in genetic testing and personalized medicine. Agilent Technologies and Roche have both reported increased investments in the region to enhance genomics capabilities, reflecting the growing demand for precision healthcare. In terms of acquisitions, Thermo Fisher Scientific completed its acquisition of a local bioinformatics company in July 2023, aiming to bolster its genomics portfolio in South America. Genomatix and Genscript have expanded their operations in Brazil, focusing on broadened research collaborations. The market is also seeing a growth surge driven by the rising prevalence of genetic disorders and an increased focus on agricultural genomics, with BGI actively supporting local research initiatives. Additionally, Eurofins Scientific has increased its laboratory capacity to meet the growing demand for genetic testing services across South America. Over the past few years, the region has also witnessed an uptick in public-private partnerships aimed at genomic research, culminating in increased investment opportunities. The South American genomics market is projected to grow significantly, reflecting the interconnectedness of healthcare and technological advancements within this emerging market landscape. ## **South America Genomics Market Segmentation Insights** ### **Genomics Market Application****Outlook** ### **Genomics Market Technology****Outlook** ### **Genomics Market End Use****Outlook** ### **Genomics Market Regional****Outlook** ## Market Drivers ### Collaborative Research Efforts Collaborative research efforts among academic institutions, government bodies, and private companies are emerging as a significant driver in the genomics market in South America. These partnerships facilitate knowledge sharing and resource pooling, which are essential for advancing genomic research. For example, initiatives like the Latin American Genome Project aim to create a comprehensive genomic database that reflects the diverse genetic makeup of the region. Such collaborations not only enhance research capabilities but also attract funding and investment, thereby strengthening the genomics market. ### Government Initiatives and Funding Government initiatives play a crucial role in shaping the genomics market in South America. Various countries in the region are increasingly recognizing the importance of genomics in healthcare and agriculture. For instance, Brazil has launched several funding programs aimed at promoting genomic research and innovation. These initiatives are expected to allocate over $200 million annually to support genomics projects. Such financial backing not only stimulates research but also encourages collaboration between public and private sectors, thereby fostering a robust environment for growth in the genomics market. ### Advancements in Genomic Technologies Technological advancements are significantly influencing the genomics market in South America. Innovations in next-generation sequencing (NGS) and bioinformatics are enhancing the efficiency and accuracy of genomic analyses. The cost of sequencing has decreased dramatically, with prices dropping to around $1,000 per genome, making it more accessible for research and clinical applications. This democratization of technology is likely to spur growth in the genomics market, as more institutions and companies can leverage these tools for various applications, including disease diagnosis and agricultural improvements. ### Rising Demand for Personalized Medicine The increasing demand for personalized medicine is a pivotal driver in the genomics market in South America. As healthcare systems evolve, there is a notable shift towards treatments tailored to individual genetic profiles. This trend is supported by advancements in genomic sequencing technologies, which have become more accessible and affordable. In South America, the market for personalized medicine is projected to grow at a CAGR of approximately 12% from 2025 to 2030. This growth is likely to be fueled by the rising prevalence of chronic diseases and the need for targeted therapies, thereby enhancing the overall landscape of the genomics market. ### Increasing Focus on Agricultural Genomics The focus on agricultural genomics is gaining momentum in South America, driven by the need for sustainable agricultural practices and food security. With a growing population, the demand for high-yield and disease-resistant crops is becoming more pressing. Genomic technologies are being utilized to develop improved crop varieties, which can withstand environmental stresses. The agricultural genomics market in South America is expected to reach approximately $1 billion by 2027, indicating a robust growth trajectory. This emphasis on agricultural innovation is likely to have a profound impact on the overall genomics market. ## Future Outlook The [Genomics Market](https://www.marketresearchfuture.com/reports/genomics-market-12283) is projected to grow at 13.25% CAGR from 2025 to 2035, driven by advancements in technology, increased healthcare spending, and rising demand for personalized medicine. **New opportunities:** - Development of targeted gene therapies for rare diseases - Expansion of genomic data analytics services - Investment in CRISPR technology for agricultural applications By 2035, the genomics market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Application: Clinical Diagnostics (Largest) vs. Personalized Medicine (Fastest-Growing) In the South America genomics market, the application segment is witnessing significant differentiation. Clinical Diagnostics holds a dominant position, commanding a substantial share of the market due to its essential role in disease identification and management. On the other hand, Personalized Medicine, while smaller in market share, is rapidly gaining attention for its tailored therapeutic approaches, highlighting a trend towards more individualized healthcare solutions. Growth trends in this segment are driven by advancements in technology and increasing demand for precision medicine. Factors such as rising healthcare expenditures and the growing prevalence of genetic disorders accelerate the adoption of genetic testing services for Drug Discovery and Clinical Diagnostics, while the Personalized Medicine segment is expected to become a major growth driver in the near future due to its innovative approach to treatment. Drug Discovery: Clinical Diagnostics (Dominant) vs. Personalized Medicine (Emerging) Clinical Diagnostics is characterized by its widespread application in hospitals and laboratories for accurate disease detection, making it the leading area in the South America genomics market. With rigorous regulatory frameworks in place, it continually evolves to incorporate new genetic information, thereby enhancing diagnostic accuracy. In contrast, Personalized Medicine is an emerging segment that focuses on customizing healthcare products and services to individual patient profiles. Its growth is propelled by technological innovations in genetic sequencing and bioinformatics, positioning it as a transformative force in patient care that seeks to improve therapeutic outcomes by addressing the unique genetic makeup of patients. ### By Technology: Sequencing (Largest) vs. CRISPR (Fastest-Growing) In the genomic sector, South America exhibits a diverse distribution of technology segments, with sequencing commanding the largest share. This dominance results from its extensive application in research and clinical diagnostics, where researchers rely heavily on sequencing for detailed genetic analysis. In contrast, CRISPR technology, while smaller in market share, is rapidly gaining traction due to its revolutionary potential in gene editing, thus attracting significant attention from both public and private sectors. Growth trends in this market segment are influenced by advances in technology and increasing interest in personalized medicine. Sequencing remains prevalent due to its foundational role in genomics, while CRISPR is recognized as the fastest-growing segment, propelled by innovations and a surge in applications like gene therapy and agricultural biotechnology. Such trends underscore the dynamic nature of the technology landscape, as companies invest in R&D to explore new possibilities. Technology: Sequencing (Dominant) vs. CRISPR (Emerging) Sequencing technology stands as the dominant force in the South American genomics market, thriving on its established methodologies and extensive utility in various applications, including diagnostics and research. Its robustness offers high accuracy in genetic data acquisition, making it invaluable for genomic research endeavors. In contrast, CRISPR technology represents an emerging powerhouse that leverages gene editing capabilities to address complex genetic challenges. The rapid advancements in CRISPR applications are driven by its versatility and cost-effectiveness, making it attractive for both commercial and academic pursuits. As investment grows in developing CRISPR solutions, its market presence is expected to expand rapidly, capturing interest across therapeutics, agriculture, and technology sectors. ### By End Use: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing) In the South America genomics market, hospitals account for the largest share, driven by their extensive investments in genomic technologies and personalized medicine. As healthcare providers increasingly adopt advanced genomic solutions, the demand for genomic testing and treatment options within hospitals is anticipated to expand significantly. Meanwhile, diagnostic laboratories are experiencing rapid growth as crucial players in the genomics space. Their ability to provide timely and accurate genomic analyses is making them increasingly vital to clinical decision-making. The growth trends in this market segment highlight the increased emphasis on personalized healthcare, with both hospitals and diagnostic laboratories at the forefront. Hospitals are leveraging genomic data for tailored patient treatments, while diagnostic laboratories are rapidly incorporating next-generation sequencing (NGS) technologies. Factors such as increased funding for genomic research and advancements in genomic technologies are driving growth across the sector, allowing these end-use segments to play pivotal roles in improving healthcare outcomes in South America. Hospitals: Dominant vs. Diagnostic Laboratories: Emerging Hospitals are presently the dominant end-use segment within the genomics market, characterized by their integration of cutting-edge genomic technologies into clinical practice. They invest heavily in genomic diagnostics, allowing for enhanced patient management and personalized treatment strategies. On the other hand, diagnostic laboratories represent an emerging force, adapting quickly to technological advancements and regulatory changes. Their agility in implementing innovative genomic tests positions them as key contributors to the market's growth dynamics. As the demand for genomic services increases, both hospitals and diagnostic laboratories will continue to evolve, ensuring comprehensive healthcare solutions that meet the needs of patients in South America. ## Regional Market Share Analysis ### Brazil : Robust Growth and Innovation Hub Brazil holds a dominant market share of 2.8 in the South American genomics sector, driven by increasing investments in biotechnology and healthcare. Key growth drivers include a rising prevalence of genetic disorders, government initiatives promoting research and development, and a growing demand for personalized medicine. Regulatory frameworks are becoming more supportive, with policies aimed at fostering innovation and collaboration in the genomics field. Infrastructure improvements, particularly in major cities, are enhancing access to genomic technologies. ### Mexico : Growing Demand and Investment Opportunities Mexico's genomics market is valued at 1.2, reflecting a burgeoning interest in genetic research and diagnostics. Key growth drivers include increasing healthcare expenditure, a rise in chronic diseases, and a focus on precision medicine. The government is actively promoting genomics through funding initiatives and partnerships with private sectors. The regulatory environment is evolving, with efforts to streamline approvals for genomic technologies, fostering a conducive atmosphere for market growth. ### Argentina : Focus on Research and Development Argentina's genomics market, valued at 1.0, is characterized by a strong emphasis on research and development. Growth is fueled by collaborations between universities and biotech firms, alongside government support for innovation. Demand for genomic testing is rising, particularly in urban areas like Buenos Aires and Córdoba, where healthcare facilities are increasingly adopting advanced genomic technologies. The competitive landscape features key players like Roche and Illumina, which are establishing a significant presence in the region. ### Rest of South America : Varied Market Dynamics Across Regions The Rest of South America holds a market value of 0.83, with diverse opportunities across different countries. Growth drivers include increasing awareness of genetic testing and healthcare improvements. Regulatory policies vary significantly, impacting market entry and expansion strategies for international players. Countries like Chile and Colombia are emerging as key markets, with local firms and international players like Thermo Fisher Scientific competing for market share. The business environment is evolving, with a focus on enhancing healthcare infrastructure. ## Competitive Benchmarking The genomics market in South America is characterized by a dynamic competitive landscape, driven by advancements in technology, increasing investments in research and development, and a growing demand for personalized medicine. Key players such as Illumina (US), Thermo Fisher Scientific (US), and Roche (CH) are at the forefront, leveraging their innovative capabilities and extensive product portfolios to capture market share. Illumina (US) focuses on next-generation sequencing technologies, while Thermo Fisher Scientific (US) emphasizes a broad range of genomic solutions, including reagents and instruments. Roche (CH) is strategically positioned in diagnostics and therapeutics, enhancing its competitive edge through continuous innovation and strategic partnerships. Collectively, these companies shape a competitive environment that is increasingly focused on technological advancements and collaborative efforts.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for dominance. However, the collective influence of major companies like BGI Genomics (CN) and Qiagen (DE) is notable, as they contribute to a competitive atmosphere that encourages innovation and strategic collaborations. In October Illumina (US) announced a partnership with a leading South American research institution to develop genomic solutions tailored to local populations. This collaboration is expected to enhance the accessibility of genomic technologies in the region, potentially leading to breakthroughs in personalized medicine and public health initiatives. Such strategic alliances are crucial for fostering innovation and expanding market reach. In September Thermo Fisher Scientific (US) launched a new line of genomic analysis tools specifically designed for the South American market. This product line aims to address the unique challenges faced by researchers in the region, thereby solidifying Thermo Fisher's position as a key player in the genomics landscape. The introduction of localized products reflects a growing trend towards customization and responsiveness to regional needs. In August Roche (CH) expanded its genomic testing capabilities by acquiring a local biotech firm specializing in genetic diagnostics. This acquisition not only enhances Roche's technological portfolio but also strengthens its foothold in the South American market. The strategic move underscores the importance of mergers and acquisitions in driving growth and innovation within the genomics sector. As of November current trends in the genomics market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence in genomic research and diagnostics. Strategic alliances are increasingly shaping the competitive landscape, fostering collaboration among key players. Looking ahead, competitive differentiation is likely to evolve, with a greater emphasis on innovation, technological advancements, and supply chain reliability, moving away from traditional price-based competition. The focus on personalized medicine and tailored genomic solutions will likely define the future trajectory of the market. ## Recent News & Developments The South America Genomics Market has experienced notable developments recently, particularly with advancements in genetic testing and personalized medicine. Agilent Technologies and Roche have both reported increased investments in the region to enhance genomics capabilities, reflecting the growing demand for precision healthcare. In terms of acquisitions, Thermo Fisher Scientific completed its acquisition of a local bioinformatics company in July 2023, aiming to bolster its genomics portfolio in South America. Genomatix and Genscript have expanded their operations in Brazil, focusing on broadened research collaborations. The market is also seeing a growth surge driven by the rising prevalence of genetic disorders and an increased focus on agricultural genomics, with BGI actively supporting local research initiatives. Additionally, Eurofins Scientific has increased its laboratory capacity to meet the growing demand for genetic testing services across South America. Over the past few years, the region has also witnessed an uptick in public-private partnerships aimed at genomic research, culminating in increased investment opportunities. The South American genomics market is projected to grow significantly, reflecting the interconnectedness of healthcare and technological advancements within this emerging market landscape. ## Report Scope | MARKET SIZE 2024 | 5.83(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 6.6(USD Billion) | | MARKET SIZE 2035 | 22.92(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 13.25% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Illumina (US), Thermo Fisher Scientific (US), Roche (CH), Agilent Technologies (US), BGI Genomics (CN), Qiagen (DE), PerkinElmer (US), Eurofins Scientific (LU) | | Segments Covered | Application, Technology, End Use | | Key Market Opportunities | Advancements in personalized medicine and gene editing technologies drive growth in the genomics market. | | Key Market Dynamics | Growing investment in genomics Research and Development drives innovation and competitive dynamics in South America. | | Countries Covered | Brazil, Mexico, Argentina, Rest of South America | ## Frequently Asked Questions **Q: What was the overall market valuation of the South America genomics market in 2024?** A: The overall market valuation was $5.83 Billion in 2024. **Q: What is the projected market valuation for the South America genomics market by 2035?** A: The projected valuation for 2035 is $22.92 Billion. **Q: What is the expected CAGR for the South America genomics market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 13.25%. **Q: Which application segment had the highest valuation in 2024 within the South America genomics market?** A: The Clinical Diagnostics segment had the highest valuation at $1.75 Billion in 2024. **Q: What is the projected valuation for the Drug Discovery segment by 2035?** A: The projected valuation for the Drug Discovery segment by 2035 is $3.43 Billion. **Q: Which technology segment is expected to grow the most by 2035 in the South America genomics market?** A: The CRISPR technology segment is expected to grow to $7.24 Billion by 2035. **Q: What was the valuation of the Genetic Testing segment in 2024?** A: The Genetic Testing segment was valued at $1.05 Billion in 2024. **Q: Which end-use segment is projected to have the highest valuation by 2035?** A: The Pharmaceutical Companies end-use segment is projected to reach $7.24 Billion by 2035. **Q: Who are the key players in the South America genomics market?** A: Key players include Illumina, Thermo Fisher Scientific, Roche, Agilent Technologies, BGI Genomics, Qiagen, PerkinElmer, and Eurofins Scientific. **Q: What was the valuation of the Microarray technology segment in 2024?** A: The Microarray technology segment was valued at $1.2 Billion in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-america-genomics-market-52466*